Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.42240Source: DataRank Database

Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine is a research paper published in JAMA Network Open (2022). On theSindex it has a DataRank of 0. It has been cited 45 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.87)OA: goldTopics (110)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

D. Claire Miller ORCID,Yuwei Sun ORCID,Benjamin F. Arnold ORCID,J. Daniel Kelly ORCID,Nisha R. Acharya ORCID

Live enrichment

PubMed:36383382 OpenAlex:https://openalex.org/W4309350393

National Institutes of Health

Grant: 2R01EY028739-06

The Impact of the Herpes Zoster Vaccine on Herpes Zoster Ophthalmicus

National Institutes of Health

Grant: 5F32EY006190-02

NEURONAL INVOLVEMENT IN OCULAR HERPETIC DISEASE

NIAID NIH HHS

Grant: K23 AI146268

NIAID NIH HHS

Grant: L30 AI126521

FWCI

5.87

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2798504/akpandak_2022_oi_221191_1667839528.24171.pdf

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2798504/akpandak_2022_oi_221191_1667839528.24171.pdf

journalhttps://doi.org/10.1001/jamanetworkopen.2022.42240

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36383382

repositoryhttps://escholarship.org/uc/item/7fh868ww

Fields of Study

Herpesvirus Infections and TreatmentsFacial Nerve Paralysis Treatment and ResearchDermatological and COVID-19 studies0302 clinical medicine03 medical and health sciencesAdultFemaleHumansMaleMiddle AgedAd26COVS1Antiviral AgentsBNT162 VaccineCohort StudiesCOVID-19COVID-19 VaccinesHerpes ZosterHerpes Zoster VaccineInfluenza, Human

MeSH Terms

COVID-19COVID-19 VaccinesBNT162 VaccineAd26COVS1AdultAntiviral AgentsFemaleHerpes ZosterHumansInfluenza, HumanMaleMiddle AgedCohort StudiesHerpes Zoster Vaccine

Keywords

MedicineVaccinationCohortShinglesCoronavirus disease 2019 (COVID-19)PandemicConfidence intervalPediatricsInternal medicineImmunologyVirusPrevention (rcdc)MaleAgingWomen's Health (rcdc)CoronavirusesCoronaviruses VaccinesBNT162 Vaccine (mesh)Human (mesh)Cohort StudiesAging (rcdc)Clinical Research (rcdc)Herpes Zoster (mesh)Herpes Zoster VaccineImmunization (rcdc)32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Original InvestigationHumans (mesh)3 Good Health and Well Being (sdg)COVID-19 (mesh)Cohort Studies (mesh)Middle AgedCoronaviruses Disparities and At-Risk PopulationsInfection (hrcs-hc)Infectious Diseases3.4 VaccinesVaccine Related (rcdc)FemaleInfectionCoronaviruses Vaccines (rcdc)HumanAdultCOVID-19 VaccinesAntiviral Agents (mesh)Clinical Sciences610Antiviral AgentsHerpes ZosterEmerging Infectious Diseases (rcdc)Vaccine RelatedClinical Research42 Health sciences (for-2020)Middle Aged (mesh)Influenza, HumanHumans3202 Clinical Sciences (for-2020)BNT162 VaccineBiomedical and Clinical SciencesAd26COVS1PreventionCOVID-19 Vaccines (mesh)Health sciencesCoronaviruses (rcdc)COVID-193.4 Vaccines (hrcs-rac)InfluenzaCoronaviruses Disparities and At-Risk Populations (rcdc)Emerging Infectious DiseasesGood Health and Well BeingInfectious Diseases (rcdc)Female (mesh)Ad26COVS1 (mesh)Herpes Zoster Vaccine (mesh)Adult (mesh)Women's HealthImmunization

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being